ATE168698T1 - Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten - Google Patents
Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheitenInfo
- Publication number
- ATE168698T1 ATE168698T1 AT89906251T AT89906251T ATE168698T1 AT E168698 T1 ATE168698 T1 AT E168698T1 AT 89906251 T AT89906251 T AT 89906251T AT 89906251 T AT89906251 T AT 89906251T AT E168698 T1 ATE168698 T1 AT E168698T1
- Authority
- AT
- Austria
- Prior art keywords
- psoriasis
- treatment
- preparations
- neuropsychiatric diseases
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19987388A | 1988-05-27 | 1988-05-27 | |
US28555988A | 1988-12-16 | 1988-12-16 | |
US07/352,313 US5063206A (en) | 1988-12-16 | 1989-05-16 | Compositions having use as treatment of neuropsychiatric deficits |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE168698T1 true ATE168698T1 (de) | 1998-08-15 |
Family
ID=27394077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89906251T ATE168698T1 (de) | 1988-05-27 | 1989-05-25 | Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0415999B1 (de) |
JP (2) | JPH0618777B2 (de) |
AT (1) | ATE168698T1 (de) |
AU (1) | AU620107B2 (de) |
CA (1) | CA1336677C (de) |
DE (1) | DE68928752T2 (de) |
IL (1) | IL90427A (de) |
WO (1) | WO1989012067A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6242564B1 (en) * | 1986-06-03 | 2001-06-05 | Candace B. Pert | Treatment of tropical spastic paresis with peptide T |
US5189022A (en) * | 1988-05-27 | 1993-02-23 | The United States Of America As Represented By The Secretary Of Health And Human Services | Composition for the treatment of chronic fatigue syndrome |
DK31991D0 (da) * | 1991-02-25 | 1991-02-25 | Carlbiotech Ltd As | Peptid og farmaceutisk praeparat indeholdende et saadant peptid |
ATE267838T1 (de) * | 1992-03-27 | 2004-06-15 | Advanced Immuni T Inc | T-peptid und damit verwandte peptide in der behandlung von entzündungen einschlies slich der multiplen sklerose |
RU2130317C1 (ru) * | 1992-03-27 | 1999-05-20 | Пептайд Текнолоджи Лимитед | Линейные или циклические пептиды, их применение, способ лечения |
US6011014A (en) * | 1992-03-27 | 2000-01-04 | Advanced Immunit, Inc. | Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis |
DE69433817T2 (de) * | 1993-09-24 | 2005-07-14 | Advanced Immuni T, Inc. | Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis |
EP0871466B1 (de) * | 1993-09-24 | 2004-05-06 | Advanced Immuni T, Inc. | Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5921613A (ja) * | 1982-07-28 | 1984-02-03 | Takeda Chem Ind Ltd | 直腸投与製剤 |
AU7544987A (en) * | 1986-06-03 | 1988-01-11 | Pert, C.B. | Small peptides which inhibit binding to t-4 receptors |
EP0249394B1 (de) * | 1986-06-03 | 1993-10-27 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Kleine Peptide, die die Bindung an T-4-Rezeptoren inhibieren und als Immunogene wirken |
US4804651A (en) * | 1987-06-09 | 1989-02-14 | Board Of Regents, The University Of Texas System | Methods and compositions for the treatment of psoriasis |
PT90657B (pt) * | 1988-05-27 | 1995-03-01 | Ortho Pharma Corp | Processo para a preparacao de peptidos que bloqueiam a ligacao de hiv-1 a proteina cd4 receptora |
-
1989
- 1989-05-25 WO PCT/US1989/002205 patent/WO1989012067A1/en active IP Right Grant
- 1989-05-25 AT AT89906251T patent/ATE168698T1/de not_active IP Right Cessation
- 1989-05-25 JP JP1506059A patent/JPH0618777B2/ja not_active Expired - Lifetime
- 1989-05-25 EP EP89906251A patent/EP0415999B1/de not_active Expired - Lifetime
- 1989-05-25 AU AU36936/89A patent/AU620107B2/en not_active Expired
- 1989-05-25 DE DE68928752T patent/DE68928752T2/de not_active Expired - Fee Related
- 1989-05-26 IL IL9042789A patent/IL90427A/en unknown
- 1989-05-29 CA CA000600999A patent/CA1336677C/en not_active Expired - Fee Related
-
1993
- 1993-09-16 JP JP5230549A patent/JP3011837B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE68928752T2 (de) | 1998-12-03 |
AU3693689A (en) | 1990-01-05 |
EP0415999A4 (en) | 1991-10-16 |
EP0415999A1 (de) | 1991-03-13 |
CA1336677C (en) | 1995-08-15 |
JPH06228001A (ja) | 1994-08-16 |
EP0415999B1 (de) | 1998-07-22 |
AU620107B2 (en) | 1992-02-13 |
JPH0618777B2 (ja) | 1994-03-16 |
DE68928752D1 (de) | 1998-08-27 |
IL90427A (en) | 1994-10-07 |
JP3011837B2 (ja) | 2000-02-21 |
WO1989012067A1 (en) | 1989-12-14 |
JPH03502928A (ja) | 1991-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0335901A4 (en) | Methods and compositions for the treatment of non-ige-mediated diseases | |
NO985975L (no) | Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav | |
FI935585A0 (fi) | Pyrrolopyrimidiner | |
DE60039752D1 (de) | Herstellung tetravalenter antikörper | |
ATE190623T1 (de) | Verwendung von steroiden zur inhibierung von angiogenesis | |
ATE100320T1 (de) | Verwendung von thromboxan-a2-rezeptorantagonisten zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von hautkrankheiten. | |
ATE158183T1 (de) | Arzneimittel zur behandlung von anxietas | |
ATE168698T1 (de) | Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten | |
ATE112317T1 (de) | Bcrf1-proteine als inhibitoren von interferon- g(g). | |
ATE174798T1 (de) | Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation | |
DE69010294D1 (de) | Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs. | |
NO970573D0 (no) | Ylidenforbindelser og deres fremstilling | |
DE3687233T2 (de) | Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten. | |
DE69422980D1 (de) | Extrakte von Piliostigma thonningii, deren Verwendung und diese enthaltende Zubereitungen | |
DE69631528D1 (de) | Serumzusammensetzungen zur hemmung von retroviren und tumorwachstum | |
TR200000916T2 (tr) | İkameli piperidin türevleri. | |
ATE76571T1 (de) | Zusammensetzung zur behandlung der haut. | |
DE3765250D1 (de) | Verwendung von 24,25-dihydroxycholecalciferol zur behandlung von harnsteinen. | |
DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
ATE88090T1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EELA | Cancelled due to lapse of time |